The Cavalier Daily
Serving the University Community Since 1890

University to receive free cancer drug

The University's Medical Center will receive a free supply of the drug Taxol as a result of a recent legal settlement, according to the Hampton Roads Daily Press.

States involved in the lawsuit claimed Bristol-Myers Squibb tried to keep the generic form of Taxol from reaching the market. As a result, Bristol-Myers Squibb must distribute vials of Taxol to medical centers around the country.

Taxol, or paciltaxel, is a chemotherapy drug used mostly in the treatment of ovarian and breast cancer, according to the University Health System Web site. It costs between $6,000 and $10,000 per patient for a standard course treatment.

In addition to receiving the vials of Taxol, the University Medical Center will receive compensation from Bristol-Myers Squibb for being overcharged for Taxol in the past. Around the country, $12 million will be spent reimbursing patients who overpaid for the drug, according to the Daily Press.

To qualify for the free Taxol, patients cannot have primary insurance, Medicare or Medicaid, and they must fall under a certain household income level.

According to the University Medical Center Web site, Taxol is a somewhat controversial drug because the American Cancer Society and National Cancer Institute have both said the risks involving Taxol outweigh the benefits.

--Compiled by Johanna Cluver

Local Savings

Puzzles
Hoos Spelling

Latest Podcast

Carolyn Dillard, the Community Partnership Manager for the University’s Center of Community Partnerships, discusses the legacy of Dr. King through his 1963 speech at Old Cabell Hall and the Center's annual MLK Day celebrations and community events. Highlighting the most memorable moments of the keynote event by Dr. Imani Perry, Dillard explored the importance of Dr. King’s lasting message of resilience and his belief that individuals should hold themselves responsible for their actions and reactions.